Drug resistance in bacteria often involves drug-tolerant persisters. Mycobacterium tuberculosis uses trehalose catalytic shift to promote persister formation, thereby developing multidrug resistant-TB (MDR-TB). Authors show that inhibiting this shift reduces MDR-TB, highlighting a potential therapeutic target for new treatments.
- Jae Jin Lee
- Daniel H. Swanson
- Hyungjin Eoh
